Gov’t approves chemical pharmaceutical industry development program through 2030
VGP - By 2030, Viet Nam strives to meet approximately 20 percent of the demand for pharmaceutical raw materials used in domestic drug manufacturing, prioritizing increased self-sufficiency in essential and strategic active pharmaceutical ingredients and other pharmaceutical raw materials.
This is part of the chemical pharmaceutical industry development program through 2030, with a vision to 2045, recently approved by the Government.
Under the program, from now to 2030, at least two advanced research and development centers for chemical pharmaceuticals will be established that meet international standards and have the capacity to conduct research, develop processes, carry out testing, scale up production, transfer technologies, and support the commercialization of chemical pharmaceutical technologies and products.
The Southeast Asian nation targets to ensure that all of domestic manufacturers of active pharmaceutical ingredients, excipients, and other pharmaceutical raw materials comply with applicable quality requirements, Good Manufacturing Practice (GMP) standards, and chemical safety regulations in accordance with the law and the standards applicable to each product category.
At least half of these manufacturing facilities will be able to adopt digital solutions for production management, quality management, and traceability.
By 2045, Viet Nam aims to achieve a higher level of self-sufficiency in the supply of essential pharmaceutical raw materials, ensuring drug security and the ability to respond to supply chain disruptions.
Viet Nam targets to become one of the countries with the capacity to manufacture, research, and develop selected high-value-added chemical pharmaceutical products, enabling it to participate more extensively in regional and global chemical pharmaceutical and pharmaceutical value chains./.